Patch test results with rubber series in the European Surveillance System on Contact Allergies (ESSCA), 2013/14

• Verfasst von: Uter, Wolfgang [VerfasserIn]
• Verfasst von: Weisshaar, Elke [VerfasserIn]
• Titel: Patch test results with rubber series in the European Surveillance System on Contact Allergies (ESSCA), 2013/14
• Verf.angabe: Wolfgang Uter, Katharine Warburton, Elke Weisshaar, Dagmar Simon, Barbara Ballmer-Weber, Vera Mahler, Thomas Fuchs, Johannes Geier and Mark Wilkinson
• E-Jahr: 2016
• Jahr: 5 June 2016
• Umfang: 8 S.
• Fussnoten: Gesehen am 28.11.2017
• Titel Quelle: Enthalten in: Contact dermatitis
• Ort Quelle: Oxford [u.a.] : Wiley-Blackwell, 1975
• Jahr Quelle: 2016
• Band/Heft Quelle: 75(2016), 6, Seite 345-352
• ISSN Quelle: 1600-0536
• DOI: doi:10.1111/cod.12651
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: clinical epidemiology
• Sach-SW: contact sensitization
• Sach-SW: patch test
• Sach-SW: rubber chemicals
• K10plus-PPN: 1565766520

Abstract

Background. Contact: allergy to rubber additives is common, particularly in patients with occupational dermatitis. Objectives: to descriptively analyse and compare patch test reactions in patients patch tested both with the baseline series and with an additional ‘rubber series’ as used in the department. Methods: patch test data from those members of the European Surveillance System on Contact Allergies (ESSCA) network (www.essca-dc.org) who also contributed data on rubber series patch test results were retrospectively analysed. Results: among 29 522 patients patch tested, 2870 were eligible, that is, patch tested both with the baseline series and with a special rubber series. Of these, 8.8% had positive reaction(s) to one of the baseline screening rubber allergens (as compared with 4.2% in all patients), most often to carba mix, 12.3% had positive reaction(s) to allergens from an additional rubber series, and 6.4% had positive reaction(s) to both. Conclusions: additional testing with a dedicated rubber series, containing break-down single ingredients of mixes from the baseline series and additional rubber allergens, is warranted in patients with suspected contact allergy to rubber, to avoid false-negative results.